Companies: 10,795·Total market cap: $144.5T
Biora Therapeutics, Inc.

Biora Therapeutics, Inc.

BIOROTCHealthcare
$0.22
+$0.00(+0.00%)
Market Cap$994994
P/E Ratio—
52W High$0.3802
52W Low$0.15
SEC Filings

Biora Therapeutics, Inc. (BIOR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001580063 · BIOR · OTC · as of Jun 8, 2026

Filing snapshot

428
Total Filings
SCHEDULE 13G/A
Latest Form
2025-08-04
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001580063 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-04-01
Fiscal Year End
Apr 1, 2024
Accession No.
0000950170-24-039423
Primary Document
bior-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001580063 · Accession 0000950170-24-039423

Latest Key Filings

10-QQuarterly Report
10-Q
2024-11-14
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2024-12-30Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-08-04
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-08-04
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-07-10
View
25-NSE25-NSE
25-NSE
2025-06-04
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-03-26
View
8-KCurrent Report
CURRENT REPORT
2024-12-30
View
8-KCurrent Report
8-K
2024-12-10
View
8-KCurrent Report
8-K
2024-11-15
View
10-QQuarterly Report
10-Q
2024-11-14
View
8-KCurrent Report
8-K
2024-11-14
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2024-11-14
View
8-KCurrent Report
8-K
2024-10-29
View
424B5424B5
424B5
2024-10-29
View
424B3424B3
424B3
2024-10-29
View
424B3424B3
424B3
2024-10-29
View
Showing 1–15 of 290 filingsForm 4 / 144 hidden· 428 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001580063  |  Exchange: OTC · Healthcare

Biora Therapeutics, Inc. (OTC: BIOR) has submitted 428 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001580063, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Biora Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Biora Therapeutics, Inc. 10-K was filed on 2024-04-01 for fiscal year ending 2024. Historical BIOR 10-K annual reports are available from 2013 through 2024.

Investors researching Biora Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ORGS SEC Filings →ISCO SEC Filings →CAIHF SEC Filings →EVFM SEC Filings →EPGNF SEC Filings →UNBX SEC Filings →HALB SEC Filings →BPTH SEC Filings →
→ BIOR Financials→ BIOR Earnings→ BIOR Insider Trades

Frequently Asked Questions

BIOR SEC Filings · 8 questions

Biora Therapeutics, Inc. (BIOR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 428 filings and access original documents at no cost. Biora Therapeutics, Inc.'s CIK is 0001580063.

BIOR SEC filingsBiora Therapeutics, Inc. SEC documentsfind BIOR 10-K